diclofenac and pf-3450074

diclofenac has been researched along with pf-3450074 in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Chen, CH; Cocklin, S; Dick, A; Ding, X; Gao, P; Huang, T; Lee, KH; Liu, X; Meuser, ME; Sun, L; Zalloum, WA; Zhan, P1
Chen, CH; Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, X; Gao, P; Huang, T; Kang, D; Lee, KH; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Xu, S; Zalloum, WA; Zhan, P1
Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, X; Huang, T; Jiang, X; Kang, D; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Tao, Y; Xu, S; Zalloum, WA; Zhan, P; Zhang, X1
Cherukupalli, S; Cocklin, S; De Clercq, E; Dick, A; Ding, D; Ding, X; Gao, S; Huang, T; Jiang, X; Kang, D; Liu, X; Meuser, ME; Pannecouque, C; Sun, L; Tao, Y; Xu, S; Zalloum, WA; Zhan, P; Zhang, X1

Other Studies

4 other study(ies) available for diclofenac and pf-3450074

ArticleYear
Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
    European journal of medicinal chemistry, 2020, Mar-15, Volume: 190

    Topics: Anti-HIV Agents; Capsid Proteins; Cell Line, Tumor; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Dynamics Simulation; Molecular Structure; Phenylalanine; Protein Binding; Structure-Activity Relationship; Triazoles; Virus Replication

2020
Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities.
    Journal of medicinal chemistry, 2020, 05-14, Volume: 63, Issue:9

    Topics: Animals; Anti-HIV Agents; Capsid Proteins; Cell Line, Tumor; Drug Design; Female; HIV-1; HIV-2; Humans; Male; Mice; Microsomes, Liver; Molecular Structure; Phenylalanine; Rats, Sprague-Dawley; Structure-Activity Relationship; Sulfonamides; Virus Replication

2020
Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors.
    European journal of medicinal chemistry, 2021, Dec-15, Volume: 226

    Topics: Anti-HIV Agents; Capsid Proteins; Dimerization; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Dynamics Simulation; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Surface Plasmon Resonance

2021
Design, synthesis, and mechanistic investigations of phenylalanine derivatives containing a benzothiazole moiety as HIV-1 capsid inhibitors with improved metabolic stability.
    European journal of medicinal chemistry, 2022, Jan-05, Volume: 227

    Topics: Anti-HIV Agents; Benzothiazoles; Capsid Proteins; Dose-Response Relationship, Drug; Drug Design; HIV-1; Humans; Microbial Sensitivity Tests; Microsomes, Liver; Molecular Structure; Phenylalanine; Structure-Activity Relationship; Virus Replication

2022